ArticleFrontiers in nutrition2026
Taste alterations in breast cancer patients undergoing chemotherapy: an observational study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Taste alterations are a common adverse effect of chemotherapy and may substantially impair quality of life, social interactions, and dietary habits. Reported incidence rates vary widely, partly due to the heterogeneity of assessment methods. This study aimed to investigate chemotherapy-induced taste alterations in patients with breast cancer using both objective (taste strips) and subjective (questionnaire-based) measures. Materials and methods: This was a prospective study conducted between July 2023 and June 2025 at the Candiolo Cancer Institute FPO-IRCCS, in Torino (Italy). Sociodemographic, clinical, anthropometric variables, and dietary habits were collected. Taste alterations were evaluated using both subjective and objective assessment tools (taste strips). Results: A total of 94 female patients were enrolled. Of these, 70 patients had completed chemotherapy and taste evaluation and were included in the statistical analyses. According to subjective assessment, all taste modalities were significantly altered from pre- to post-chemotherapy evaluation, whereas one third of patients exhibited taste impairment when assessed using taste strips. The two methods showed limited agreement. In multiple regression models adjusted for age, smoking status, and pack-years, higher education level was inversely associated with subjective deterioration in sour ( Conclusion: Taste alterations affect a substantial proportion of patients with breast cancer undergoing chemotherapy. The low agreement observed between subjective and objective measures suggests that these methods may assess distinct aspects of taste dysfunction and should be interpreted accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.